tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ATHJF

Antisense Therapeutics Schedules Hybrid Annual General Meeting
Company AnnouncementsAntisense Therapeutics Schedules Hybrid Annual General Meeting
2M ago
Antisense Therapeutics Limited to Hold Annual General Meeting
PremiumCompany Announcements
Antisense Therapeutics Limited to Hold Annual General Meeting
2M ago
Percheron Therapeutics Plans Major Securities Issuance
PremiumCompany Announcements
Percheron Therapeutics Plans Major Securities Issuance
2M ago
Percheron Therapeutics Unveils Significant Security Issuance
PremiumCompany Announcements
Percheron Therapeutics Unveils Significant Security Issuance
2M ago
Percheron Therapeutics Requests Trading Halt for Capital Raising
PremiumCompany Announcements
Percheron Therapeutics Requests Trading Halt for Capital Raising
2M ago
Percheron Therapeutics Advances with Avicursen Study
PremiumCompany AnnouncementsPercheron Therapeutics Advances with Avicursen Study
3M ago
Percheron Therapeutics Unveils Corporate Update
Premium
Company Announcements
Percheron Therapeutics Unveils Corporate Update
4M ago
Percheron’s Avicursen Shows Hope for Epilepsy
Premium
Company Announcements
Percheron’s Avicursen Shows Hope for Epilepsy
4M ago
Percheron Therapeutics Maintains Full Governance Compliance
PremiumCompany Announcements
Percheron Therapeutics Maintains Full Governance Compliance
4M ago
Percheron Therapeutics Reports Increased Annual Loss
PremiumCompany Announcements
Percheron Therapeutics Reports Increased Annual Loss
4M ago
Percheron Therapeutics Advances DMD Drug Development
PremiumCompany Announcements
Percheron Therapeutics Advances DMD Drug Development
5M ago
Percheron Therapeutics Options Issue Unveiled
PremiumCompany Announcements
Percheron Therapeutics Options Issue Unveiled
6M ago
Percheron Therapeutics Welcomes New CFO
PremiumCompany AnnouncementsPercheron Therapeutics Welcomes New CFO
6M ago
Percheron Therapeutics Welcomes New Medical Advisor
Premium
Company Announcements
Percheron Therapeutics Welcomes New Medical Advisor
7M ago
Percheron Therapeutics to Present at BIO 2024
Premium
Company Announcements
Percheron Therapeutics to Present at BIO 2024
7M ago
Percheron Therapeutics Advances DMD Drug Study
PremiumCompany Announcements
Percheron Therapeutics Advances DMD Drug Study
7M ago
Percheron Reports Positive ATL1102 Study Outcomes
PremiumCompany Announcements
Percheron Reports Positive ATL1102 Study Outcomes
7M ago
Percheron’s Drug Candidate Receives WHO Name Proposal
PremiumCompany Announcements
Percheron’s Drug Candidate Receives WHO Name Proposal
8M ago
Percheron Therapeutics Nears Clinical Milestone
PremiumCompany Announcements
Percheron Therapeutics Nears Clinical Milestone
8M ago
Platinum Adjusts Stake in Percheron Therapeutics
PremiumCompany AnnouncementsPlatinum Adjusts Stake in Percheron Therapeutics
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >